The coronavirus vaccine was developed faster than any vaccine in history. It took just 332 days from the first sequencing of the virus genome to the first vaccines given to the public.
Academic rigour, journalistic flair
Articles on Vaccines
Displaying 401 - 420 of 782 articles
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
COVID-19 vaccines have very specific storage requirements that make shipping a difficult task. Two ideas – fulfillment centers and cross-docking – could help overcome some distribution challenges.
Health systems around the US are on the cusp of receiving COVID-19 vaccines. At the end of this months-long effort are the nitty-gritty details of how health care providers are giving people the vaccine.
The reason the vaccine appears to have worked better in participants who initially received only half a dose is still somewhat of a mystery.
If supplies of COVID-19 vaccine are initially limited, who should be vaccinated first? A mathematical model shows when and why it’s best to start with the young, and when older people should go first.
COVID-19 vaccine testing on children is just getting started, and only in adolescents.
Trafficking of counterfeit medicines is on the rise, with Interpol seizing £10.4m of counterfeit COVID related products in March 2020
A 1904 revolt against mandatory smallpox inoculation taught Brazilian health officials a deadly lesson on how to vaccinate a skeptical public. Today President Bolsonaro seems to ignore that history.
A pharmaceutical supply chain expert explains the challenges of distributing the COVID-19 vaccines from Pfizer and Moderna that need to be kept at very low temperatures.
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
‘Sensible’ public figures have far less influence on our behaviour than it seems
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Unprecedented efforts are driving the global push for a safe and effective vaccine. If and when we have one (or more), here’s how it’s likely to be rolled out in Australia.
Vaccines do more than just protect against the disease they were designed for. They also have so-called non-specific effects that can improve overall health.
It’s hoped the NHS’s use of celebrity endorsement will influence the uptake of the COVID-19 vaccine – and research backs that up.
There are three promising COVID-19 trials.
Lots of viruses have disappeared before. But experts think COVID will stay with us for a long time to come.
Job Board
-
Assistant Editor - 1 year cadetship
-
Program Development Officer - Business Processes
-
Executive Dean, Faculty of Health
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
Top contributors
-
Professorial Fellow, University of Canberra
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor of Biology, Rochester Institute of Technology
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Professor of Microbiology, School of Medicine, University of Washington
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Immunology, RMIT University
-
Assistant Professor of Political Science, Oklahoma State University
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Senior Lecturer; MD, Victoria University
-
Associate Professor and ARC Future Fellow, The University of Western Australia
